Slilaty Steve N. 4
4 · Sunshine Biopharma, Inc · Filed Feb 22, 2022
Insider Transaction Report
Form 4
Slilaty Steve N.
DirectorCEO and President10% Owner
Transactions
- Disposition to Issuer
Series B Preferred Stock
2022-02-18$0.10/sh−990,000$99,000→ 10,000 total
Footnotes (1)
- [F1]Dr. Slilaty returned 990,000 shares of Series B Preferred Stock to the Issuer for a redemption price equal to the stated value of $0.10 per share.